Search

Abbott Laboratories

Chiusa

SettoreSettore sanitario

102.98 0.45

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

101.62

Massimo

103.17

Metriche Chiave

By Trading Economics

Entrata

-149M

928M

Vendite

1.4B

13B

P/E

Media del settore

33.363

56.432

EPS

1.31

Rendimento da dividendi

2.43

Margine di Profitto

7.369

Dipendenti

122,000

EBITDA

-465M

1.8B

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+21.17% upside

Dividendi

By Acuity

Rendimento da dividendi

Media del settore

2.43%

2.27%

Utili prossimi

14 ott 2026

Prossima data del Dividendo

16 nov 2026

Prossima data del' Ex Dividendo

15 ott 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

16B

180B

Apertura precedente

102.53

Chiusura precedente

102.98

Notizie sul Sentiment di mercato

By Acuity

39%

61%

81 / 339 Classifica in Healthcare

Abbott Laboratories Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

21 set 2026, 23:00 UTC

Abbott Laboratories is trading modestly higher in after-market hours, recovering from earlier declines but remains below its 20-day moving average.

16 set 2026, 19:16 UTC

Abbott Laboratories shares are modestly higher but remain below their 20-day moving average and near the lower end of their one-month range.

15 set 2026, 23:01 UTC

Abbott Laboratories shares are higher in after-market hours, reflecting broader market trends. No specific company news was identified to explain the movement.

14 set 2026, 22:51 UTC

Abbott Laboratories shares are lower in after-market hours, reflecting broader market declines amid rising crude oil prices due to geopolitical supply concerns.

12 set 2026, 00:01 UTC

Abbott Laboratories shares are higher in after-market trading, despite being below the 20-day moving average and a trend of lower closes.

11 set 2026, 23:01 UTC

Abbott Laboratories shares are higher in after-market trading, settling at a cumulative return of 1.60%. The U.S. budget deficit for August was $167 billion.

10 set 2026, 19:16 UTC

News

Abbott Laboratories received FDA approval for its TactiFlex Duo catheter. Shares are lower today, continuing a trend of declining prices over the past week.

9 set 2026, 23:26 UTC

News

Abbott Laboratories received U.S. FDA approval for its TactiFlex Duo ablation catheter. Shares are higher in after-market trading, reflecting a recovery from recent declines.

8 set 2026, 20:02 UTC

News

Abbott Laboratories shares are lower, reaching a four-week low of $106.72 amid weakness in the Health Care Equipment sector despite FDA approval for its ablation catheter.

4 set 2026, 20:07 UTC

Abbott Laboratories shares are lower, influenced by a strong jobs report that increased selling pressure across risk assets. The stock remains near its one-month trading range low.

3 set 2026, 23:31 UTC

Abbott Laboratories shares declined in after-market trading, reflecting ongoing weakness. The stock is near the lower end of its one-month range.

2 set 2026, 23:56 UTC

Abbott Laboratories shares are lower in after-market hours, reflecting a decline since Wednesday's close amid weaker-than-expected job growth reported by ADP.

1 set 2026, 23:51 UTC

Abbott Laboratories shares are higher in after-market hours amid notable trading activity. Rising oil prices and inflation concerns may influence Federal Reserve policy decisions.

31 ago 2026, 23:32 UTC

Correlated Moves

Abbott Laboratories sees gains in after-market trading, reflecting strength in the health care equipment sector and broader positive trends among correlated assets.

28 ago 2026, 23:16 UTC

Correlated Moves

Abbott Laboratories shares are higher in after-market hours, following a modest gain earlier, alongside Medtronic PLC's advance in the health care equipment sector.

27 ago 2026, 22:51 UTC

Abbott Laboratories shares are trading higher in after-market hours, reversing three consecutive daily declines. No specific news was identified to explain the movement.

26 ago 2026, 23:21 UTC

Abbott Laboratories is higher in after-market hours, reflecting broader market gains. The stock remains above its 20-day moving average despite recent fluctuations.

25 ago 2026, 23:26 UTC

Abbott Laboratories shares declined after-market, with no specific news identified. Broader market sentiment was affected by falling crude oil prices amid eased geopolitical tensions.

24 ago 2026, 23:01 UTC

Abbott Laboratories shares are trading lower in after-market hours. Broader market weakness and geopolitical tensions are contributing to the price movement.

21 ago 2026, 23:01 UTC

Abbott Laboratories shares were lower in after-market trading, despite being above the 20-day moving average and near the upper end of their one-month range.

20 ago 2026, 23:01 UTC

News

Abbott Laboratories settles litigation for $670 million over preterm infant formulas, trading lower in after-market hours following the news.

19 ago 2026, 23:01 UTC

Abbott Laboratories shares are lower in after-market hours following a volatile session, despite trading above their 20-day moving average. No specific news was identified.

18 ago 2026, 23:16 UTC

Shares of Abbott Laboratories are higher in after-market trading, remaining above the 20-day moving average and near the upper end of the one-month range.

17 ago 2026, 23:41 UTC

Abbott Laboratories shares are trading lower in after-market hours. Broader market volatility is linked to rising crude oil prices and geopolitical tensions.

14 ago 2026, 23:02 UTC

Abbott Laboratories shares are trading higher in after-market hours, showing strength above the 20-day moving average despite mixed market sentiment and declining U.S. retail sales.

13 ago 2026, 23:01 UTC

Abbott Laboratories shares are lower in after-market trading, with no specific news identified to explain the decline. The stock remains above its 20-day moving average.

12 ago 2026, 23:46 UTC

Abbott Laboratories shares are lower in after-market trading, with no specific news identified for the decline. Broader market optimism follows recent inflation data.

11 ago 2026, 19:16 UTC

News

Abbott Laboratories announced a partnership with Google Health to enhance glucose management through AI. Shares are trading higher amid positive market sentiment.

10 ago 2026, 23:46 UTC

Abbott Laboratories shares are lower in after-market hours, with no specific news identified for the decline. The stock remains above its 20-day moving average.

7 ago 2026, 23:06 UTC

Abbott Laboratories shares declined slightly in after-market trading. The stock remains above its 20-day moving average and near the upper end of its one-month range.

Confronto tra pari

Modifica del prezzo

Abbott Laboratories Previsione

Obiettivo di Prezzo

By TipRanks

21.17% in crescita

Previsioni per 12 mesi

Media 124.333 USD  21.17%

Alto 135 USD

Basso 112 USD

Basato su 15 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Abbott Laboratories - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

15 ratings

15

Acquista

0

Mantieni

0

Vendi

Sentiment

By Acuity

81 / 339 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.